BioStock: Iconovo and ISR develop new covid-19 inhalation vaccine

Yesterday, Inhalation device company Iconovo, which offers complete inhalation products, signed an agreement with immunotherapy company ISR Immune System Regulation. The agreement concerns the development of an inhalation vaccine against Covid-19 in Iconovo’s disposable inhaler ICOone. The parties see significant potential for the product, which is expected to be tested thoroughly in humans in the second half of 2021.

Read the full article at biostock.se: 

https://www.biostock.se/en/iconovo-and-isr-develop-new-covid-19-inhalation-vaccine/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se